Description: Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
Home Page: www.kiniksa.com
KNSA Technical Analysis
Clarendon House
Hamilton,
HM 11
Bermuda
Phone:
808 189 6257
Officers
| Name | Title |
|---|---|
| Mr. Sanj K. Patel | CEO & Chairman |
| Dr. John F. Paolini | Sr. VP & Chief Medical Officer |
| Mr. Mark Ragosa C.F.A. | Sr. VP & CFO |
| Mr. Eben Tessari | Sr. VP & COO |
| Mr. Michael R. Megna CPA | Chief Accounting Officer & Group VP of Fin. |
| Ms. Mei Jang | Sr. VP of Technical Operations |
| Rachel Frank | Associate Director of Investor Relations |
| Mr. Chad Morin | Sr. VP & Chief Compliance Officer |
| Ms. Madelyn Zeylikman | SVP, Gen. Counsel & Sec. |
| Ms. Melissa Manno | Sr. VP & Chief HR Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 7.7749 |
| Price-to-Book MRQ: | 2.8247 |
| Price-to-Sales TTM: | 6.1425 |
| IPO Date: | 2018-05-24 |
| Fiscal Year End: | December |
| Full Time Employees: | 215 |